Startup tests resistance to HIV drugs

June 8, 2014 - Boston Herald

by Marie Szaniszlo

A simple, fast, affordable test developed by a Boston-based MassChallenge finalist is able to determine which drugs HIV is resistant to, saving money and lives.

Using a technology called Pan Degenerate Amplification and Adaptation, Aldatu Biosciences allows doctors to match patients with drugs the HIV won't be resistant to, based on the genetics of the virus.

"If resistance is present, switching people to effective drugs improves quality of life and saves money by reducing the risk of new infections," Aldatu CEO David Raiser said. "If resistance is not present, money is saved by not switching patients to more expensive drugs unnecessarily. There are clear economic and public health benefits to performing the test, regardless of the result." Continue reading...

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in you in box.

seventh name
Thu, 9/18/2014 - 3:22pm
Thu, 9/18/2014 - 3:13pm

Learn what pre-exposure prophylaxis (PrEP) is, how it works, what the research says, new guidelines for using Truvada as PrEP, and more.

The Well Project interviews Maria Mejia: International HIV Activist, Community Advisory Board member and A Girl Like Me blogger.

Dating can be tricky for HIV+ women. Whom do you tell and when? Get tips on meeting people, dating, disclosing, and more.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>